Innovative,
independent,
close to the patient

We are a biotech company that independently develops innovative drugs and diagnostics for personalised treatment of cardiovascular diseases. We have a unique product pipeline that we are consistently moving into clinical trials. Our lead compound has been successfully tested in two Phase II studies.

advancecor therapeutic agents for prevention and treatment of acute arterial thrombosis

advancecor therapeutic agents for prevention and treatment of acute arterial thrombosis

Revacept

Therapeutic agent for the prevention and treatment of acute arterial thrombosis.

GPVI-inhibitory
antibodies

Preventing the activation of blood platelets, protecting against heart attacks and strokes.

Cyclic peptides

New type of drug for the treatment of thyroid diseases.

Our
Pipeline

We are a biotech company that independently develops innovative drugs and diagnostics for personalised treatment of cardiovascular diseases. We have a unique product pipeline that we are consistently moving into clinical trials. Our lead compound has been successfully tested in two Phase II studies.

Our service for you

Expert GLP Measurements
and Biomedical Services

You are looking for a service partner for the development of GLP-based measurement procedures? advanceCOR is approved for ELISA-based measurement procedures and different platelet assays according to the quality criteria of Good Laboratory Practice (GLP). For our customers we take over, for example, the investigation of pharmacokinetics in the context of preclinical or clinical projects. We also carry out the determination of antibodies in blood samples and other fluids on behalf of our clients.

Our Investors